Press Releases Ypsomed Group

Burgdorf – Ypsomed now supplies the Polish company Polfa Tarchomin S. A. with its reusable and affordable YpsoPen. The YpsoPen is being introduced to the Polish market and will be used to administer Polfa Tarchomin's insulin. Negotiations are in place to expand cooperation to other countries.

Press Releases Ypsomed Group

Burgdorf – In business year 2014/15 Ypsomed Group posted consolidated sales of CHF 306.6 million, which represents an increase of 11% year on year.

Press Releases Ypsomed Group

Burgdorf – After a transitional period of several months, the titles of the Ypsomed Holding AG will again be included in the SPI starting 12 May 2015. The SPI is the broad market index for the Swiss equity market. In addition to the Swiss Market Index, the SPI is Switzerland's most closely observed stock market index and contains virtually all of the shares traded on the SIX Swiss Exchange from companies based in Switzerland or the Principality of Liechtenstein.

Press Releases Ypsomed Group

Burgdorf – Ypsomed has entered into an exclusive agreement to supply Indian pharmaceutical major Lupin Limited (Lupin) with its reusable and affordable YpsoPen. The YpsoPen would be used to administer Lupin's insulin.

Press Releases Ypsomed Group

Burgdorf – The long-standing partnership between the French pharmaceutical group Sanofi and the Ypsomed Group will be bolstered by a new major project: starting in late 2016, Ypsomed plans to manufacture components for injection systems on an additional dedicated production line. The additional annual capacity will be in the double-digit millions.